Groundbreaking Research In Cannabis Therapeutics

Groundbreaking Research In Cannabis Therapeutics

Groundbreaking research in cannabis therapeutics with Scott Karolchyk, Director of Formulation Development for MedPharm Holdings. MedPharm’s team of scientists and experts is uniquely positioned to perform groundbreaking research in cannabis therapeutics. MedPharm’s team includes chemists, a PhD in medicinal and natural products chemistry, compounding pharmacist and formulation development expert. MedPharm can create any dosage form with any desired combination of cannabinoids and, due to the possession of the only Cannabis Research License granted by the State of Colorado, MedPharm can also administer placebos out of its main facility.

groundbreaking research

This means that MedPharm can provide study medications, placebos, and support for Randomized-Controlled Trials (RCTs) and more. Scott is an accomplished product development leader with extensive experience in pharmaceutical formulation design and development, compounded preparation research, and business management. He is proactive and tenacious in applying knowledge to project initiatives, utilizing communication across divisions to influence and drive project teams with a particular focus on the successful delivery of new formulations, clinical trial supplies, regulatory submissions, and commercial deliverables.